Antiviral Antiviral Antiviral Antiviral Antiviral Antiviral
Clinical trial ID No. (Registry) Intervention to prevent infection Participant size Randomized Status Country (Pharma.)
2020-000936-23 (EU-CTR)
Arm A: lopinavir/ritonavir Arm B: interferon beta 1a Arm C: remdesivir
3000
Yes
Recruiting
France
NCT04302766 (ClinicalTrials.gov) Arm A: remdesivir Arm B: standard treatment
Unspecified
Unspecified
Available
USA
NCT04292899 (ClinicalTrials.gov) Arm A: remdesivir Arm B: standard treatment
400
Yes
Recruiting
USA & Asia
NCT04292730 (ClinicalTrials.gov Arm A: remdesivir Arm B: standard treatment
600
Yes
Recruiting
USA & Asia
NCT04280705 (ClinicalTrials.gov)
Arm A: remdesivir
394
Yes
Recruiting
USA & South Koria
2020-000841-15 (EU-CTR) Arm A: remdesivir Arm B: standard treatment
400
Yes
Recruiting
Worldwide
2020-000842-32 (EU-CTR) Arm A: remdesivir Arm B: standard treatment
600
Yes
Recruiting
Worldwide
NCT04252664 (ClinicalTrials.gov)
Arm A: remdesivir
308
Yes
Recruiting
China
NCT04257656 (ClinicalTrials.gov)
Arm A: remdesivir
453
Yes
Recruiting
China
NCT04315948 (ClinicalTrials.gov) Arm A: remdesivir Arm B: standard treatment
3100
Yes
Recruiting
France
ChiCTR2000029600 (ICTPR) Arm A: favipiravir and interferon alpha Atomisation
90
No
Recruiting
China
ChiCTR2000029544 (ICTPR)
Arm A: favipiravir
30
Yes
Not recruiting
China
ChiCTR2000029548 (ICTPR)
Arm A: favipiravir
30
Yes
Not recruiting
China
NCT04273763 (ClinicalTrials.gov) Arm A: favipiravir and bromhexine (mucolytic), umifenovir, interferon a2b
60
Yes
Recruiting
China (WanBangDe Pharm. Group)
ChiCTR2000030113 (ICTPR)
Arm A: favipiravir
20
Yes
Recruiting
China
ChiCTR2000030254 (ICTPR)
Arm A: favipiravir
240
Yes
Recruiting
China
ChiCTR2000030987 (ICTPR) Arm A: favipiravir and chloroquine Arm B: favipiravir
150
Yes
Recruiting
China
NCT04310228 (ClinicalTrials.gov) Arm A: favipiravir and tocilizumab Arm B: favipiravir
150
Yes
Recruiting
China
JPRN-jRCTs041190120 (ICTPR) Arm A: immediate favipiravir (Day 1–10) Arm B: delayed favipiravir (Day 6–15)
86
Yes
Recruiting
Japan
ChiCTR2000029996 (ICTPR) Arm A: low-dose favipiravir Arm B: medium-dose favipiravir Arm C: high-dose favipiravir
60
Yes
Recruiting
China
NCT04303299 (ClinicalTrials.gov)
Arm A: lopinavir/ritonavir and favipiravir
80
Yes
Not recruiting
Thailand
ChiCTR2000030922 (ICTPR) Arm A: ribavirin and interferon alpha 2a Arm B: umifenovir and ribavirin
30
Yes
Recruiting
China
NCT04276688 (ClinicalTrials.gov) Arm A: ribavirin + lopinavir/ritonavir + interferon beta 1b
70
Yes
Recruiting
Hong Kong
ChiCTR2000029387 (ICTPR) Arm A: ribavirin and interferon alpha-1b Arm B: ribavirin, lopinavir/ritonavir, and interferon alpha-1b
108
Unspecified
Recruiting
China
ChiCTR2000029609 (ICTPR) Arm A (mild–moderate): chloroquine Arm B (mild–moderate): lopinavir/ritonavir + chloroquine Arm C (severe): chloroquine
205
No
Recruiting
China
NCT04303299 (ClinicalTrials.gov)
Arm A: oseltamivir and chloroquine
80
Yes
Not recruiting
Thailand
IRCT20100228003449N27 (ICTPR) Arm A: hydroxychloroquine, lopinavir/ ritonavir, and interferon beta 1b Arm B: hydroxychloroquine and lopinavir/ritonavir
30
Yes
Recruiting
Iran
IRCT20100228003449N28 (ICTPR) Arm A: hydroxychloroquine, lopinavir/ ritonavir, and interferon beta 1a Arm B: hydroxychloroquine and lopinavir/ritonavir
30
Yes
Recruiting
Iran
IRCT20100228003449N29 (ICTPR Arm A: hydroxychloroquine, lopinavir/ ritonavir, and sofosbuvir/ledipasvir Arm B: hydroxychloroquine and lopinavir/ritonavir
50
Yes
Recruiting
Iran
JPRN-jRCTs031190227 (ICTPR) Arm A: lopinavir/ritonavir and hydroxychloroquine
50
Unspecified
Not recruiting
Japan
NCT04315948 (ClinicalTrials.gov) Arm A: remdesivir Arm B: lopinavir/ritonavir Arm C: lopinavir/ritonavir and interferon beta 1a Arm D: hydroxychloroquine Arm E: standard treatment
3100
Yes
Recruiting
France
NCT04273763 (ClinicalTrials.gov) Arm A: bromhexine (mucolytic), umifenovir, interferon a2b, and favipiravir Arm B: umifenovir and interferon a2b
60
Yes
Recruiting
China
ChiCTR2000030254 (ICTPR) Arm A: favipiravir Arm B: umifenovir
240
Yes
Recruiting
China
ChiCTR2000030922 (ICTPR) Arm A: interferon alpha 2a and ribavirin Arm B: umifenovir and ribavirin
30
Yes
Recruiting
China
NCT04252885 (ClinicalTrials.gov) Arm A: lopinavir/ritonavir + basic treatment (unspecified) Arm B: umifenovir + basic treatment (unspecified)
125
Yes
Recruiting
China
ChiCTR2000029573 (ICTPR) Arm A: umifenovir Arm B: Novaferon and umifenovir Arm C: lopinavir/ritonavir Arm D: umifenovir Arm E: novaferon and lopinavir/ritonavir Arm F: novaferon and umifenovir
480
Yes
Not recruiting
China
ChiCTR2000029621 (ICTPR) Arm A: umifenovir Arm B: standard treatment
380
Yes
Recruiting
China
NCT04254874 (ClinicalTrials.gov) Arm A: umifenovir Arm B: umifenovir and pegylated interferon alpha 2b
100
Yes
Recruiting
China
NCT04255017 (ClinicalTrials.gov) Arm A: umifenovir Arm B: oseltamivir Arm C: lopinavir/ritonavir
400
Yes
Recruiting
China
ChiCTR2000029993 (ICTPR) Arm A: umifenovir and Liushen capsule Arm B: standard treatment
40
Yes
Recruiting
China
ChiCTR2000029592 (ICTPR) Arm A: umifenovir Arm B: without umifenovir
100
Unspecified
Not recruiting
China
NCT04261270 (ClinicalTrials.gov) Arm A: ASC09 and oseltamivir Arm B: ritonavir and oseltamivir Arm C: oseltamivir
60
Yes
Recruiting
China
NCT04303299 (ClinicalTrials.gov) Arm A: oseltamivir and chloroquine Arm B: lopinavir/ritonavir and favipiravir Arm C: lopinavir/ritonavir and oseltamivir Arm D: lopinavir/ritonavir and oseltamivir
80
Yes
Not recruiting
Thailand
ChiCTR2000029609 (ICTPR) Arm A(mild–moderate): lopinavir/ritonavir Arm B(mild–moderate): lopinavir/ritonavir + chloroquine Arm C (severe): lopinavir/ritonavir
205
Yes
Recruiting
China
ChiCTR2000029600 (ICTPR) Arm A: interferon alpha atomisation Arm B: lopinavir/ritonavir and interferon alpha atomisation
90
No
Recruiting
China
NCT04261907 (ClinicalTrials.gov) Arm A: ASC09/ritonavir Arm B: lopinavir/ritonavir
160
Yes
Recruiting
China (Ascletis Pharm)
ChiCTR2000029548 (ICTPR) Arm A: baloxavirmarboxil Arm B: favipiravir Arm C: lopinavir/ritonavir
30
Yes
Not recruiting
China
ChiCTR2000029541 (ICTPR) Arm A: darunavir/cobicistat and thymosin Arm B: lopinavir/ritonavir and thymosin Arm C: thymosin
100
Yes
Not recruiting
China
NCT04291729 (ClinicalTrials.gov) Arm A: darunavir/ritonavir and atomised interferon Arm B: peginterferon a2 Arm C: interferon alpha (Novaferon) Arm D: lopinavir/ritonavir Arm E: atomised interferon + Chinese medicine (unspecified)
50
Yes
Recruiting
China (Ascletis Pharm)
ChiCTR2000030535 (ICTPR) Arm A: ebastine and interferon alpha inhalation and lopinavir Arm B: interferon alpha inhalation and lopinavir
100
Yes
Recruiting
China
2020-001113-21 (EU-CTR)
Arm A: lopinavir/ritonavir Arm B: dexamethasone Arm C: interferon beta 1a Arm D: placebo
2000
Yes
Recruiting
UK
ChiCTR2000029468 (ICTPR) Arm A: lopinavir/ritonavir and emtricitabine/tenofovir Arm B: lopinavir/ritonavir
120
Unspecified
Not recruiting
China
ChiCTR2000030166 (ICTPR) Arm A: lopinavir/ritonavir and interferon alpha 2b and Qing-Wen Bai-Du-Yin granules Arm B: lopinavir/ritonavir and interferon alpha 2b
20
Yes
Not recruiting
China
ChiCTR2000030218 (ICTPR) Arm A: lopinavir/ritonavir and Xiyanping injection Arm B: ritonavir
80
Unspecified
Recruiting
China
ChiCTR2000029539 (ICTPR) Arm A: lopinavir/ritonavir Arm B: standard treatment
328
Yes
Recruiting
China
ChiCTR2000029496 (ICTPR) Arm A: Novaferonatomisation inhalation Arm B: lopinavir/ritonavir Arm C: Novaferon and lopinavir/ritonavir
90
Yes
Recruiting
China
NCT04252274 (ClinicalTrials.gov)
Arm A: darunavir and cobicistat Arm B: standard treatment
30
Yes
Recruiting
China
NCT04304053 (ClinicalTrials.gov) Arm A: darunavir/cobicistat Arm B: isolation
3040
Yes
Recruiting
Spain